Clinical Trial Update: A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation [Phase 3]

View source ↗

Summary

A second Phase 3 study of the NicVAX vaccine versus placebo as an aid for smoking cessation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• NicVAX (nicotine vaccine)

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED